Insider Transactions Reported by 15 Insiders of Corbus Pharmaceuticals Holdings, Inc.

Symbol
CRBP on Nasdaq
Location
Norwood, MA

Insiders trading volume in the past year

Corbus Pharmaceuticals Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $26,863,987 -$344,012 -1.3% 11 Dec 2025
Rachael Louise Brake Chief Scientific Officer $6,958,000 13 Feb 2023
Craig Stuart Millian Chief Operating Officer $4,645,186 13 Feb 2023
Yuval Cohen Chief Executive Officer, Director $1,356,631 -$579,156 -30% 13 Feb 2026
Sean F. Moran Chief Financial Officer $752,569 -$257,525 -25% 13 Feb 2026
Dominic Smethurst Chief Medical Officer $745,203 -$77,176 -9.4% 02 Mar 2026
Ian Hodgson Chief Operating Officer $377,123 -$25,791 -6.4% 17 Feb 2026
ALAN F. HOLMER Director $254,268 30 May 2025
AVERY W. CATLIN Director $144,332 30 May 2024
Rachelle Suzanne Jacques Director $140,135 30 May 2025
Yong Ben Director $140,135 30 May 2025
Anne Altmeyer Director $126,915 -$31,826 -20% 20 Oct 2025
John Kenneth Jenkins Director $120,582 -$20,465 -15% 30 May 2025
Peter Salzmann Director $97,322 30 May 2024
Winston Kung Director $77,434 30 May 2025

Recent Insider Transactions by Companies or Individuals for Corbus Pharmaceuticals Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.